Location History:
- Grenchen, CH (2015 - 2023)
- La Chaux-de-Fonds, CH (2014 - 2024)
Company Filing History:
5 out of 64 
4 out of 12 
2 out of 1,451 
Years Active: 2014-2024
Title: Darko Skegro: A Pioneer in Immunoglobulin Innovations
Introduction
Darko Skegro is a notable inventor based in La Chaux-de-Fonds, Switzerland. He has contributed significantly to the field of immunology, holding a remarkable portfolio of nine patents. His work aims to innovate therapies that can target and treat various diseases by redirecting the immune system.
Latest Patents
Among his latest innovations are the patents for CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their production. This invention pertains to hetero-dimeric immunoglobulins that are designed to target both the human CD3 antigen and the human CD38 antigen. Additionally, it includes methods for producing antibodies that specifically bind to the human CD38 antigen and their derivatives, intended for therapeutic or diagnostic applications.
Another significant patent involves the production of T cell retargeting hetero-dimeric immunoglobulins. This invention describes immunoglobulins or their fragments that can bind to CD3 and a disease-associated antigen. These hetero-dimeric immunoglobulins are engineered to facilitate hetero-dimer formation during expression and can be efficiently purified using a Protein A differential purification technique.
Career Highlights
Darko Skegro has been associated with various esteemed companies in the pharmaceutical field. Notably, he has worked at Glenmark Pharmaceuticals S.A. and Ichnos Sciences S.A. His contributions in these organizations have been instrumental in advancing therapeutic solutions in immunology.
Collaborations
Throughout his career, Darko has collaborated with several talented individuals, including Stanislas Blein and Romain Ollier. These collaborations have likely enhanced the effectiveness of his innovations and driven forward the development of new therapeutic approaches.
Conclusion
In conclusion, Darko Skegro's innovative contributions to the field of immunology, particularly through his numerous patents, exemplify his dedication to improving health outcomes. His work in developing specialized immunoglobulins represents a significant advancement in targeted therapeutic strategies. As he continues to innovate, the impact of his inventions on medicine and patient care is poised to grow.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.